4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol
C22H23F2N5OS — CID 167503517
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol
4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol (PubChem CID 167503517) has the molecular formula C22H23F2N5OS and a molecular weight of 443.52 g/mol. Its IUPAC name is 4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol.
Molecular Properties
| Compound Name | 4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol |
|---|---|
| PubChem CID | 167503517 |
| Molecular Formula | C22H23F2N5OS |
| Molecular Weight | 443.52 g/mol |
| Exact Mass | 443.16 |
| IUPAC Name | 4-fluoro-2-[6-[3-[(3-fluorocyclobutyl)amino]pyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol |
| SMILES | Cc1ncc(-c2cc(O)c(-c3ccc(N4CCC(NC5CC(F)C5)C4)nn3)cc2F)s1 |
| InChI | InChI=1S/C22H23F2N5OS/c1-12-25-10-21(31-12)16-9-20(30)17(8-18(16)24)19-2-3-22(28-27-19)29-5-4-14(11-29)26-15-6-13(23)7-15/h2-3,8-10,13-15,26,30H,4-7,11H2,1H3 |
| InChIKey | IBNCBRSLZRECSK-UHFFFAOYSA-N |
| XLogP | 4.09 |
| TPSA | 74.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.52 |
| LogP ≤ 5 | 4.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167503517 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.